Challenges in Perioperative Medication Management. Learning Objectives. Case 1. » Appropriate use of beta-blockers. Management of diabetes drugs

Similar documents
Perioperative Medication Use

Perioperative Medicine:

2017 PERIOPERATIVE MEDICINE SYMPOSIUM Peri-operative use of immunosuppression in rheumatology patients

Hot Topics: The Future of Diabetes Management Cutting Edge Medication and Technology-Based Care

Beta-blockers: Now what? Annemarie Thompson, MD Assistant Professor of Anesthesia and Medicine Vanderbilt University Medical Center

Oral and Injectable Non-insulin Antihyperglycemic Agents

The Many Faces of T2DM in Long-term Care Facilities

Timely!Insulinization In!Type!2! Diabetes,!When!and!How

Coverage Criteria: Express Scripts, Inc. monograph dated 12/15/ months or as otherwise noted by indication

Diabetes and the Heart

Oral Hypoglycemics and Risk of Adverse Cardiac Events: A Summary of the Controversy

Choosing a Diabetes Strategy Where to Start and Where to Go

Joslin Diabetes Center Joslin Diabetes Forum 2013: The Impact of Comorbidities on Glucose Control Scenario 2: Reduced Renal Function

RHEUMATOID ARTHRITIS DRUGS

Type 2 Diabetes: Where Do We Start with Treatment? DIABETES EDUCATION. Diabetes Mellitus: Complications and Co-Morbid Conditions

Metformin. Sulfonylurea. Thiazolidinedione. Insulin

Preoperative Cardiac Evaluation:

Perioperative Decision Making The decision has been made to proceed with operative management timing and site of surgery the type of anesthesia preope

A factorial randomized trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

Glucagon-like peptide-1 (GLP-1) Agonists Drug Class Prior Authorization Protocol

Endo 2 SLO Practice (online) Page 1 of 7

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

PIOGLITAZONE and METFORMIN HYDROCHLORIDE Tablets USP, for oral use Initial U.S. Approval: 2005

Rheumatology Therapeutics: Perioperative DMARD Management, Infection and Malignancy Risks, Vaccination Considerations. Heather Hansen, MD

Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery

Clinical Controversies in Perioperative Medicine

Pioglitazone and Metformin Hydrochloride Tablets USP, for oral use Initial U.S. Approval: 2005

PIOGLITAZONE and METFORMIN HYDROCHLORIDE Tablets, for oral use Initial U.S. Approval: 2005

Xeljanz (tofacitinib), Xeljanz XR (tofacitinib extended-release)

Sodium-Glucose Co-Transporter 2 (SGLT-2) Inhibitors Drug Class Prior Authorization Protocol

Guidelines PATHOLOGY: FATAL PERIOPERATIVE MI NON-PMI N = 25 PMI N = 42. Prominent Dutch Cardiovascular Researcher Fired for Scientific Misconduct

Comparative Effectiveness and Safety of Diabetes Medications for Adults with Type 2 Diabetes

ETANERCEPT Generic Brand HICL GCN Exception/Other ETANERCEPT ENBREL GUIDELINES FOR USE INITIAL CRITERIA (NOTE: FOR RENEWAL CRITERIA SEE BELOW)

SESSION 5 2:20 3:35 pm

Update on Perioperative Medicine. Update on Perioperative Medicine. Question 1: Clinical Risk Prediction. for the Office-based Practitioner

HIGHLIGHTS OF PRESCRIBING INFORMATION

The Death of Sulfonylureas? A Review of New Diabetes Medications

Conflicts of Interest. Evaluation of Cardiac and Pulmonary Risk in the Preop Patient. Introduction. Risk Assessment. Risk Assessment: RCRI

LATE BREAKING STUDIES IN DM AND CAD. Will this change the guidelines?

Clinical Controversies in Perioperative Medicine

Rheumatoid Arthritis. By: Hadi Esmaily (PharmD., BCCP, MBA) Department of Clinical Pharmacy, Shahid Beheshti Medical University

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

4/27/2015. Cardiac Events #1 cause of postoperative complications/ mortality- CHF, complete heart block, MI,

CASE A2 Managing Between-meal Hypoglycemia

IDF Regions and global projections of the number of people with diabetes (20-79 years), 2013 and Diabetes Atlas -sixth Edition: IDF 2013

Regulatory Status FDA- approved indication: Simponi and Simponi ARIA are tumor necrosis factor (TNF) blockers indicated for the treatment of: (2-3)

Glucose Control drug treatments

Sarcoidosis Case. Robert P. Baughman Interstitial Lung Disease and Sarcoidosis Clinic University of Cincinnati, USA. WASOG: educational material

CURRENT CONTROVERSIES IN DIABETES CARE

Reviewing Diabetes Guidelines. Newsletter compiled by Danny Jaek, Pharm.D. Candidate

Metformin Hydrochloride

OBESITY IN TYPE 2 DIABETES

Managing Perioperative Diabetes What s new? Kathryn A. Myers MD FRCPC Chair Chief Division of GIM Professor of Medicine Western University

Comparative Effectiveness, Safety, and Indications of Insulin Analogues in Premixed Formulations for Adults With Type 2 Diabetes Executive Summary

Clinical Controversies in Perioperative Medicine!

egfr > 50 (n = 13,916)

第十五章. Diabetes Mellitus

Type II Diabetes Improving Blood Sugar Control. Geneva Clark Briggs, Pharm.D., BCPS

Practical Strategies for the Clinical Use of Incretin Mimetics CME/CE. CME/CE Released: 09/15/2009; Valid for credit through 09/15/2010

Incretin-based Therapies for Type 2 Diabetes Comparisons Between Glucagon-like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors

Limitations of Use: Glumetza is not used for the treatment of type 1 diabetes or ketoacidosis (1).

ADALIMUMAB Generic Brand HICL GCN Exception/Other ADALIMUMAB HUMIRA GUIDELINES FOR USE INITIAL CRITERIA (NOTE: FOR RENEWAL CRITERIA SEE BELOW)

Special Situations 1

Learning Objectives. Impact of Diabetes II UPDATES IN TYPE 2 DIABETES. David Doriguzzi, PA-C

BIOLOGIC THERAPY : A NEW OPTION FOR TREATMENT JUVENILE IDIOPATHIC ARTHRITIS DR TON THAT HOANG

Objectives. Kidney Complications With Diabetes. Case 10/21/2015

Old oral antidiabetic agents in the armamentarium of diabetes mellitus treatment: Safety and efficacy

Perioperative Cardiac Management. Emma Sargsyan, MD, FACP

Index. Note: Page numbers of article titles are in boldface type.

GLP-1 receptor agonists for type 2 diabetes currently available in the U.S.

Diabetic Nephropathy 2009

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES HUMIRA PEDIATRIC

The information in this guide comes from a government-funded review of research about pills for type 2 diabetes.

1 P a g e. Systemic Juvenile Idiopathic Arthritis (SJIA) (1.3) Patients 2 years of age and older with active systemic juvenile idiopathic arthritis.

3/8/2011. Julie M. Sease, Pharm D, BCPS, CDE Associate Professor of Pharmacy Practice Presbyterian College School of Pharmacy

INFLIXIMAB Remicade (infliximab), Inflectra (infliximab-dyyb), Ixifi* (infliximabqbtx), Renflexis (infliximab-abda)

CONTRAINDICATIONS: Hypersensitivity to the active substance or to any of the excipients

Management of Type 2 Diabetes Mellitus. Heather Corn, MD, MS Endocrinology, Diabetes, and Metabolism

Newer and Expensive treatment of diabetes. Endocrinology Visiting Associate Professor Institute of Medicine TUTH

Cardiovascular Benefits of Two Classes of Antihyperglycemic Medications

Disclosure. Learning Objectives. Case. Diabetes Update: Incretin Agents in Diabetes-When to Use Them? I have no disclosures to declare

Quick Guide MEDICATIONS 7th Edition Evan Sisson, Pharm.D., MHA, CDE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Proposed Health Technology Appraisal

Dipeptidyl-Peptidase 4 (DPP-4) Inhibitors Drug Class Prior Authorization Protocol

YOU HAVE DIABETES. Angie O Connor Community Diabetes Nurse Specialist 25th September 2013

Canadian Society of Internal Medicine Annual Meeting 2016 Montreal, QC

Cohen: Well, hi to my listeners, this is Dr. Marc Cohen, and I am happy again to discuss with you advances in the efficacy and safety of TNF

Cimzia. Cimzia (certolizumab pegol) Description

IMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS

Metformin should be considered in all patients with type 2 diabetes unless contra-indicated

Clinical Pearls in Renal Medicine

What s New in Diabetes Medications. Jena Torpin, PharmD

ABFM Diabetes SAM Part 4

Risk Factors for Infection Following Total Joint Arthroplasty in Rheumatoid Arthritis

National Horizon Scanning Centre. Saxagliptin (BMS ) for type 2 diabetes. April 2008

MANAGEMENT OF TYPE 2 DIABETES

Regulatory Status FDA- approved indication: Simponi and Simponi ARIA are tumor necrosis factor (TNF) blockers indicated for the treatment of:

Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone

Metabolic Syndrome and Chronic Kidney Disease

Management of Type 2 Diabetes Cardiovascular Outcomes Trials Tom Blevins MD Texas Diabetes and Endocrinology Austin, Texas

Transcription:

Challenges in Perioperative Medication Management Dimitriy Levin, MD Assistant Professor of Medicine University of Colorado Hospital Medicine Group Learning Objectives» Appropriate use of beta-blockers Management of diabetes drugs Management of immunosuppressive drugs Case 1 70 year-old female with history of myocardial infarction Undergoing total knee arthroplasty Metoprolol 50 mg two times a day Heart rate 85

Case 2 55 year-old male with no known coronary artery disease Undergoing abdominal aortic aneurysm repair History of diabetes with nephropathy (creatinine 2.3) Heart rate 80 Perioperative Beta-blockers Protect against myocardial ischemia in the perioperative period Recommended for select high-risk populations in the 2007 ACC/AHA perioperative guidelines POISE trial Non-cardiac surgery patients randomized to placebo or metoprolol XL Metoprolol XL 100 mg 2-4 hours preop Metoprolol XL 100 mg within 6 hours post-op Metoprolol XL 200 mg daily starting 12 hours after the first post-op dose for 30 days Lancet. 2008;371:1839-1847.

POISE trial Included 8,351 patients from 190 hospitals in 23 countries Metoprolol group had a decrease in non-fatal MI 4.2% vs. 5.7% in the placebo group Metoprolol group had an increase in strokes 1.0% vs. 0.5% in the placebo group Lancet. 2008;371:1839-1847. Post-POISE ACC/AHA 2009 update Continue beta-blockers if taking for appropriate indications Beneficial in select high-risk populations Titrate to heart rate goal of 50-70 Routine administration of high-dose betablockers without dose titration may be harmful J Am Coll Cardiol. 2009;54:2102-2128. High-risk populations High-risk surgery Vascular High-risk patient Revised Cardiac Risk Index (RCRI) > 1 Coronary artery disease Cerebrovascular disease Congestive heart failure Chronic kidney disease (creatinine > 2 mg/dl) Diabetes J Am Coll Cardiol. 2009;54:2102-2128.

Case 1 70 year-old female with history of myocardial infarction Undergoing total knee arthroplasty Metoprolol 50 mg two times a day Heart rate 85 Case 2 55 year-old male with no known coronary artery disease Undergoing abdominal aortic aneurysm repair History of diabetes with nephropathy (creatinine 2.3) Heart rate 80 Beta-blockers Outline» Diabetes drugs Immunosuppressive drugs

Case 3 56 year-old female with diabetes undergoing appendectomy Metformin 1000 mg twice a day Pioglitazone 45 mg daily NPH insulin 40 units in the morning, 20 units at night Oral Diabetes Drugs Metformin Risk of lactic acidosis in renal failure FDA Black Box Warning to discontinue before any intravascular radiocontrast study or surgical procedure Stop 24 hours before surgery Restart 48-72 hours after Confirm normal renal function before restarting Med Clin N Am. 2009;93:1031-1047. Oral Diabetes Drugs Sulfonylureas (glimepiride, glipizide, glyburide) Stop the night before surgery Incretins (exenatide, sitagliptin) Safe to continue Thiazolidinediones (pioglitazone, rosiglitazone) Safe to continue

Insulins Regular/lispro/aspart/glulisine: stop 4 hours before surgery NPH: Half the dose before surgery with D5 drip perioperatively Glargine/detemir: no dose adjustment Insulin pump: continue basal rate Med Clin N Am. 2009;93:1031-1047. Case 3 56 year-old female with diabetes undergoing appendectomy Metformin 1000 mg twice a day Pioglitazone 45 mg daily NPH insulin 40 units in the morning, 20 units at night Beta-blockers Outline Diabetes drugs» Immunosuppressive drugs

Case 4 62 year-old male with rheumatoid arthritis undergoing bowel resection Prednisone 20 mg daily Etanercept 50 mg weekly Corticosteroids Surgery triggers release of 50-150 mg cortisol For patients on chronic corticosteroids Continue home corticosteroid dose Add a stress dose to cover the surgery Endocrinol Metab Clin N Am. 2003;32:367-383. Stress-dose Corticosteroids Minor surgery Local anesthesia, duration less than one hour Hydrocortisone 25 mg IV or methylprednisolone 5 mg IV during surgery Endocrinol Metab Clin N Am. 2003;32:367-383.

Stress-dose Corticosteroids Moderate surgery Lower extremity vascular, joint replacement, open cholecystectomy Hydrocortisone 50-75 mg IV or methylprednisolone 10-15 mg IV during surgery Taper to baseline dose over 1-2 days Endocrinol Metab Clin N Am. 2003;32:367-383. Stress-dose Corticosteroids Major surgery Cardiothoracic, vascular, Whipple Methylprednisolone 10 mg IV every 8 hours starting in surgery Taper to baseline dose over 2-3 days Hydrocortisone not recommended due to potential for excessive fluid retention at doses exceeding 100 mg/day Endocrinol Metab Clin N Am. 2003;32:367-383. DMARDs Hydroxychloroquine Safe to continue Azathioprine, leflunomide, sulfasalazine Stop the day before surgery Resume 3 days after surgery Methotrexate Risk of wound complications vs. risk of disease progression

Biologics TNF inhibitors (adalimumab, etanercept, infliximab) IL1 antagonists (anakinra) Anti-CD20 (rituximab) Risk of wound complications vs. risk of disease progression Stop 1 week before surgery Resume 1 week after surgery Arthritis Rheum. 2008;59:762-784. Case 4 62 year-old male with rheumatoid arthritis undergoing bowel resection Prednisone 20 mg daily Etanercept 50 mg weekly Summary Beta-blockers Beneficial in select high-risk patients Should be titrated to heart rate goals Diabetes drugs Glycemic control vs. risk of hypoglycemia Immunosuppressive drugs Home dose plus stress-dose for steroids Hold DMARDs and biologics